nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—PPARG—melanoma	0.45	0.727	CbGaD
Repaglinide—ALB—melanoma	0.169	0.273	CbGaD
Repaglinide—ALB—Vemurafenib—melanoma	0.101	0.502	CbGbCtD
Repaglinide—CYP3A4—Temozolomide—melanoma	0.0577	0.287	CbGbCtD
Repaglinide—CYP3A4—Vemurafenib—melanoma	0.0316	0.157	CbGbCtD
Repaglinide—CYP3A4—Docetaxel—melanoma	0.0108	0.054	CbGbCtD
Repaglinide—PPARG—dermis—melanoma	0.00707	0.232	CbGeAlD
Repaglinide—PPARG—leg—melanoma	0.00466	0.153	CbGeAlD
Repaglinide—PPARG—hindlimb—melanoma	0.00417	0.137	CbGeAlD
Repaglinide—PPARG—appendage—melanoma	0.00357	0.117	CbGeAlD
Repaglinide—PPARG—endothelium—melanoma	0.00216	0.0708	CbGeAlD
Repaglinide—Vasculitis—Vemurafenib—melanoma	0.00208	0.027	CcSEcCtD
Repaglinide—PPARG—blood vessel—melanoma	0.00199	0.0653	CbGeAlD
Repaglinide—Tooth disorder—Temozolomide—melanoma	0.0016	0.0208	CcSEcCtD
Repaglinide—PPARG—neck—melanoma	0.00142	0.0467	CbGeAlD
Repaglinide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00113	0.0146	CcSEcCtD
Repaglinide—Hepatic enzyme increased—Temozolomide—melanoma	0.0011	0.0142	CcSEcCtD
Repaglinide—Oedema peripheral—Vemurafenib—melanoma	0.001	0.013	CcSEcCtD
Repaglinide—Erythema multiforme—Vemurafenib—melanoma	0.000964	0.0125	CcSEcCtD
Repaglinide—Eye disorder—Vemurafenib—melanoma	0.000952	0.0124	CcSEcCtD
Repaglinide—Cardiac disorder—Vemurafenib—melanoma	0.000946	0.0123	CcSEcCtD
Repaglinide—PPARG—skin of body—melanoma	0.000921	0.0302	CbGeAlD
Repaglinide—Alopecia—Vemurafenib—melanoma	0.000901	0.0117	CcSEcCtD
Repaglinide—Erythema—Vemurafenib—melanoma	0.000887	0.0115	CcSEcCtD
Repaglinide—Malnutrition—Vemurafenib—melanoma	0.000887	0.0115	CcSEcCtD
Repaglinide—Back pain—Vemurafenib—melanoma	0.000858	0.0111	CcSEcCtD
Repaglinide—Myocardial ischaemia—Docetaxel—melanoma	0.000858	0.0111	CcSEcCtD
Repaglinide—KCNJ11—head—melanoma	0.000855	0.0281	CbGeAlD
Repaglinide—PPARG—mammalian vulva—melanoma	0.00084	0.0276	CbGeAlD
Repaglinide—ABCC8—head—melanoma	0.000787	0.0258	CbGeAlD
Repaglinide—Arthralgia—Vemurafenib—melanoma	0.000755	0.00981	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00075	0.00974	CcSEcCtD
Repaglinide—Anaphylactic shock—Vemurafenib—melanoma	0.000724	0.0094	CcSEcCtD
Repaglinide—Skin disorder—Vemurafenib—melanoma	0.000703	0.00913	CcSEcCtD
Repaglinide—Acute coronary syndrome—Bleomycin—melanoma	0.000678	0.00881	CcSEcCtD
Repaglinide—Myocardial infarction—Bleomycin—melanoma	0.000674	0.00876	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00066	0.00857	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000636	0.00826	CcSEcCtD
Repaglinide—Bronchitis—Temozolomide—melanoma	0.000626	0.00813	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000625	0.00812	CcSEcCtD
Repaglinide—Constipation—Vemurafenib—melanoma	0.000619	0.00804	CcSEcCtD
Repaglinide—Hyperglycaemia—Carmustine—melanoma	0.000607	0.00789	CcSEcCtD
Repaglinide—PPARG—head—melanoma	0.000601	0.0197	CbGeAlD
Repaglinide—KCNJ11—lymph node—melanoma	0.000598	0.0196	CbGeAlD
Repaglinide—Hyperglycaemia—Temozolomide—melanoma	0.000587	0.00762	CcSEcCtD
Repaglinide—Urinary tract infection—Carmustine—melanoma	0.000584	0.00758	CcSEcCtD
Repaglinide—Hepatitis—Dactinomycin—melanoma	0.000576	0.00748	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000575	0.00747	CcSEcCtD
Repaglinide—Urinary tract infection—Temozolomide—melanoma	0.000564	0.00733	CcSEcCtD
Repaglinide—Cardiac failure congestive—Docetaxel—melanoma	0.000552	0.00717	CcSEcCtD
Repaglinide—Hepatobiliary disease—Temozolomide—melanoma	0.000549	0.00713	CcSEcCtD
Repaglinide—Alopecia—Bleomycin—melanoma	0.000546	0.00709	CcSEcCtD
Repaglinide—Erythema multiforme—Dactinomycin—melanoma	0.000544	0.00707	CcSEcCtD
Repaglinide—Sinusitis—Temozolomide—melanoma	0.000544	0.00707	CcSEcCtD
Repaglinide—Erythema—Bleomycin—melanoma	0.000538	0.00698	CcSEcCtD
Repaglinide—Hypersensitivity—Vemurafenib—melanoma	0.000533	0.00693	CcSEcCtD
Repaglinide—Oedema peripheral—Carmustine—melanoma	0.000531	0.0069	CcSEcCtD
Repaglinide—Visual disturbance—Docetaxel—melanoma	0.000528	0.00686	CcSEcCtD
Repaglinide—Hepatitis—Temozolomide—melanoma	0.000521	0.00677	CcSEcCtD
Repaglinide—Visual impairment—Carmustine—melanoma	0.000519	0.00675	CcSEcCtD
Repaglinide—Oedema peripheral—Temozolomide—melanoma	0.000513	0.00666	CcSEcCtD
Repaglinide—Pruritus—Vemurafenib—melanoma	0.000512	0.00665	CcSEcCtD
Repaglinide—Alopecia—Dactinomycin—melanoma	0.000509	0.00661	CcSEcCtD
Repaglinide—Eye disorder—Carmustine—melanoma	0.000504	0.00654	CcSEcCtD
Repaglinide—Visual impairment—Temozolomide—melanoma	0.000502	0.00652	CcSEcCtD
Repaglinide—Erythema—Dactinomycin—melanoma	0.000501	0.00651	CcSEcCtD
Repaglinide—Diarrhoea—Vemurafenib—melanoma	0.000495	0.00643	CcSEcCtD
Repaglinide—Erythema multiforme—Temozolomide—melanoma	0.000492	0.0064	CcSEcCtD
Repaglinide—Eye disorder—Temozolomide—melanoma	0.000487	0.00632	CcSEcCtD
Repaglinide—Cardiac disorder—Temozolomide—melanoma	0.000483	0.00628	CcSEcCtD
Repaglinide—Arrhythmia—Carmustine—melanoma	0.000481	0.00625	CcSEcCtD
Repaglinide—Leukopenia—Bleomycin—melanoma	0.000481	0.00625	CcSEcCtD
Repaglinide—Alopecia—Carmustine—melanoma	0.000476	0.00619	CcSEcCtD
Repaglinide—Immune system disorder—Temozolomide—melanoma	0.00047	0.00611	CcSEcCtD
Repaglinide—Malnutrition—Carmustine—melanoma	0.000469	0.00609	CcSEcCtD
Repaglinide—Erythema—Carmustine—melanoma	0.000469	0.00609	CcSEcCtD
Repaglinide—Vomiting—Vemurafenib—melanoma	0.00046	0.00598	CcSEcCtD
Repaglinide—Alopecia—Temozolomide—melanoma	0.00046	0.00598	CcSEcCtD
Repaglinide—Chest pain—Bleomycin—melanoma	0.000458	0.00594	CcSEcCtD
Repaglinide—Rash—Vemurafenib—melanoma	0.000457	0.00593	CcSEcCtD
Repaglinide—Dermatitis—Vemurafenib—melanoma	0.000456	0.00592	CcSEcCtD
Repaglinide—Back pain—Carmustine—melanoma	0.000454	0.00589	CcSEcCtD
Repaglinide—Headache—Vemurafenib—melanoma	0.000454	0.00589	CcSEcCtD
Repaglinide—Malnutrition—Temozolomide—melanoma	0.000453	0.00589	CcSEcCtD
Repaglinide—Erythema—Temozolomide—melanoma	0.000453	0.00589	CcSEcCtD
Repaglinide—Leukopenia—Dactinomycin—melanoma	0.000449	0.00583	CcSEcCtD
Repaglinide—Anaphylactic shock—Bleomycin—melanoma	0.000439	0.0057	CcSEcCtD
Repaglinide—Oedema—Bleomycin—melanoma	0.000439	0.0057	CcSEcCtD
Repaglinide—Back pain—Temozolomide—melanoma	0.000439	0.0057	CcSEcCtD
Repaglinide—Nausea—Vemurafenib—melanoma	0.00043	0.00559	CcSEcCtD
Repaglinide—Thrombocytopenia—Bleomycin—melanoma	0.00043	0.00558	CcSEcCtD
Repaglinide—Angina pectoris—Docetaxel—melanoma	0.000422	0.00548	CcSEcCtD
Repaglinide—PPARG—lymph node—melanoma	0.000421	0.0138	CbGeAlD
Repaglinide—Leukopenia—Carmustine—melanoma	0.00042	0.00545	CcSEcCtD
Repaglinide—Oedema—Dactinomycin—melanoma	0.000409	0.00531	CcSEcCtD
Repaglinide—Leukopenia—Temozolomide—melanoma	0.000406	0.00527	CcSEcCtD
Repaglinide—Hypertension—Carmustine—melanoma	0.000405	0.00526	CcSEcCtD
Repaglinide—Palpitations—Temozolomide—melanoma	0.000401	0.0052	CcSEcCtD
Repaglinide—Thrombocytopenia—Dactinomycin—melanoma	0.000401	0.0052	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Bleomycin—melanoma	0.0004	0.00519	CcSEcCtD
Repaglinide—Chest pain—Carmustine—melanoma	0.000399	0.00519	CcSEcCtD
Repaglinide—ALB—lymph node—melanoma	0.000395	0.013	CbGeAlD
Repaglinide—Paraesthesia—Bleomycin—melanoma	0.000394	0.00512	CcSEcCtD
Repaglinide—Hypertension—Temozolomide—melanoma	0.000391	0.00508	CcSEcCtD
Repaglinide—Arthralgia—Temozolomide—melanoma	0.000386	0.00501	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000383	0.00498	CcSEcCtD
Repaglinide—Oedema—Carmustine—melanoma	0.000383	0.00497	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000383	0.00497	CcSEcCtD
Repaglinide—Acute coronary syndrome—Docetaxel—melanoma	0.00038	0.00494	CcSEcCtD
Repaglinide—Myocardial infarction—Docetaxel—melanoma	0.000378	0.00491	CcSEcCtD
Repaglinide—Jaundice—Docetaxel—melanoma	0.000376	0.00488	CcSEcCtD
Repaglinide—Thrombocytopenia—Carmustine—melanoma	0.000375	0.00487	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000373	0.00484	CcSEcCtD
Repaglinide—Anaphylactic shock—Temozolomide—melanoma	0.00037	0.00481	CcSEcCtD
Repaglinide—Oedema—Temozolomide—melanoma	0.00037	0.00481	CcSEcCtD
Repaglinide—Hepatobiliary disease—Docetaxel—melanoma	0.000365	0.00474	CcSEcCtD
Repaglinide—Thrombocytopenia—Temozolomide—melanoma	0.000362	0.00471	CcSEcCtD
Repaglinide—Skin disorder—Temozolomide—melanoma	0.000359	0.00467	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Carmustine—melanoma	0.000349	0.00453	CcSEcCtD
Repaglinide—Urticaria—Bleomycin—melanoma	0.000348	0.00453	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—melanoma	0.000347	0.00451	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—melanoma	0.000346	0.0045	CcSEcCtD
Repaglinide—Paraesthesia—Carmustine—melanoma	0.000344	0.00447	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—melanoma	0.000341	0.00443	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000337	0.00438	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dactinomycin—melanoma	0.000335	0.00435	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—melanoma	0.000334	0.00434	CcSEcCtD
Repaglinide—Paraesthesia—Temozolomide—melanoma	0.000332	0.00432	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Carmustine—melanoma	0.000331	0.00429	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—melanoma	0.000328	0.00425	CcSEcCtD
Repaglinide—Constipation—Carmustine—melanoma	0.000327	0.00425	CcSEcCtD
Repaglinide—Dyspepsia—Temozolomide—melanoma	0.000326	0.00423	CcSEcCtD
Repaglinide—Eye disorder—Docetaxel—melanoma	0.000324	0.0042	CcSEcCtD
Repaglinide—Abdominal pain—Dactinomycin—melanoma	0.000323	0.0042	CcSEcCtD
Repaglinide—Hypersensitivity—Bleomycin—melanoma	0.000323	0.0042	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—melanoma	0.000321	0.00418	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Temozolomide—melanoma	0.000319	0.00415	CcSEcCtD
Repaglinide—Constipation—Temozolomide—melanoma	0.000316	0.00411	CcSEcCtD
Repaglinide—Gastrointestinal pain—Carmustine—melanoma	0.000313	0.00407	CcSEcCtD
Repaglinide—Immune system disorder—Docetaxel—melanoma	0.000313	0.00406	CcSEcCtD
Repaglinide—Pruritus—Bleomycin—melanoma	0.00031	0.00403	CcSEcCtD
Repaglinide—Arrhythmia—Docetaxel—melanoma	0.000309	0.00402	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—melanoma	0.000306	0.00398	CcSEcCtD
Repaglinide—Abdominal pain—Carmustine—melanoma	0.000303	0.00393	CcSEcCtD
Repaglinide—Gastrointestinal pain—Temozolomide—melanoma	0.000303	0.00393	CcSEcCtD
Repaglinide—Erythema—Docetaxel—melanoma	0.000302	0.00392	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—melanoma	0.000302	0.00392	CcSEcCtD
Repaglinide—Hypersensitivity—Dactinomycin—melanoma	0.000301	0.00392	CcSEcCtD
Repaglinide—Urticaria—Temozolomide—melanoma	0.000294	0.00382	CcSEcCtD
Repaglinide—Abdominal pain—Temozolomide—melanoma	0.000293	0.0038	CcSEcCtD
Repaglinide—Back pain—Docetaxel—melanoma	0.000292	0.00379	CcSEcCtD
Repaglinide—Hypersensitivity—Carmustine—melanoma	0.000282	0.00366	CcSEcCtD
Repaglinide—Diarrhoea—Dactinomycin—melanoma	0.00028	0.00364	CcSEcCtD
Repaglinide—Vomiting—Bleomycin—melanoma	0.000279	0.00362	CcSEcCtD
Repaglinide—Rash—Bleomycin—melanoma	0.000277	0.00359	CcSEcCtD
Repaglinide—Dermatitis—Bleomycin—melanoma	0.000276	0.00359	CcSEcCtD
Repaglinide—Hypersensitivity—Temozolomide—melanoma	0.000273	0.00354	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—melanoma	0.00027	0.00351	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—melanoma	0.000266	0.00346	CcSEcCtD
Repaglinide—Diarrhoea—Carmustine—melanoma	0.000262	0.0034	CcSEcCtD
Repaglinide—Pruritus—Temozolomide—melanoma	0.000262	0.0034	CcSEcCtD
Repaglinide—Nausea—Bleomycin—melanoma	0.000261	0.00338	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—melanoma	0.00026	0.00338	CcSEcCtD
Repaglinide—Vomiting—Dactinomycin—melanoma	0.00026	0.00338	CcSEcCtD
Repaglinide—Rash—Dactinomycin—melanoma	0.000258	0.00335	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—melanoma	0.000257	0.00333	CcSEcCtD
Repaglinide—Arthralgia—Docetaxel—melanoma	0.000257	0.00333	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000255	0.00331	CcSEcCtD
Repaglinide—Diarrhoea—Temozolomide—melanoma	0.000253	0.00329	CcSEcCtD
Repaglinide—Anaphylactic shock—Docetaxel—melanoma	0.000246	0.0032	CcSEcCtD
Repaglinide—Oedema—Docetaxel—melanoma	0.000246	0.0032	CcSEcCtD
Repaglinide—Vomiting—Carmustine—melanoma	0.000243	0.00316	CcSEcCtD
Repaglinide—Nausea—Dactinomycin—melanoma	0.000243	0.00316	CcSEcCtD
Repaglinide—Rash—Carmustine—melanoma	0.000241	0.00314	CcSEcCtD
Repaglinide—Dermatitis—Carmustine—melanoma	0.000241	0.00313	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—melanoma	0.000241	0.00313	CcSEcCtD
Repaglinide—Headache—Carmustine—melanoma	0.00024	0.00312	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—melanoma	0.000239	0.0031	CcSEcCtD
Repaglinide—Vomiting—Temozolomide—melanoma	0.000235	0.00306	CcSEcCtD
Repaglinide—Rash—Temozolomide—melanoma	0.000233	0.00303	CcSEcCtD
Repaglinide—Dermatitis—Temozolomide—melanoma	0.000233	0.00303	CcSEcCtD
Repaglinide—Headache—Temozolomide—melanoma	0.000232	0.00301	CcSEcCtD
Repaglinide—Nausea—Carmustine—melanoma	0.000227	0.00295	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000224	0.00291	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—melanoma	0.000221	0.00287	CcSEcCtD
Repaglinide—Nausea—Temozolomide—melanoma	0.00022	0.00285	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—melanoma	0.000217	0.00281	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—melanoma	0.000212	0.00276	CcSEcCtD
Repaglinide—Constipation—Docetaxel—melanoma	0.00021	0.00273	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—melanoma	0.000201	0.00261	CcSEcCtD
Repaglinide—Abdominal pain—Docetaxel—melanoma	0.000195	0.00253	CcSEcCtD
Repaglinide—Hypersensitivity—Docetaxel—melanoma	0.000181	0.00235	CcSEcCtD
Repaglinide—Pruritus—Docetaxel—melanoma	0.000174	0.00226	CcSEcCtD
Repaglinide—Diarrhoea—Docetaxel—melanoma	0.000168	0.00219	CcSEcCtD
Repaglinide—Vomiting—Docetaxel—melanoma	0.000156	0.00203	CcSEcCtD
Repaglinide—Rash—Docetaxel—melanoma	0.000155	0.00202	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—melanoma	0.000155	0.00201	CcSEcCtD
Repaglinide—Headache—Docetaxel—melanoma	0.000154	0.002	CcSEcCtD
Repaglinide—Nausea—Docetaxel—melanoma	0.000146	0.0019	CcSEcCtD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	2.44e-05	0.000336	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—VCAN—melanoma	2.44e-05	0.000336	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—melanoma	2.43e-05	0.000334	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—FASN—melanoma	2.42e-05	0.000333	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SYK—melanoma	2.4e-05	0.00033	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CDKN2B—melanoma	2.39e-05	0.000328	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SLC5A5—melanoma	2.38e-05	0.000327	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIP4K2A—melanoma	2.35e-05	0.000324	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC6A11—melanoma	2.35e-05	0.000324	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGAV—melanoma	2.35e-05	0.000324	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT3—melanoma	2.35e-05	0.000324	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC6A11—melanoma	2.34e-05	0.000322	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIP4K2A—melanoma	2.34e-05	0.000322	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PRKCA—melanoma	2.33e-05	0.00032	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—VDR—melanoma	2.33e-05	0.00032	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.31e-05	0.000318	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ERCC2—melanoma	2.31e-05	0.000318	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNA2—melanoma	2.3e-05	0.000316	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CD44—melanoma	2.3e-05	0.000316	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GNAQ—melanoma	2.3e-05	0.000316	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTAP—melanoma	2.29e-05	0.000315	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	2.28e-05	0.000314	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTAP—melanoma	2.28e-05	0.000313	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PRKCA—melanoma	2.26e-05	0.000311	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.25e-05	0.000309	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ERCC2—melanoma	2.24e-05	0.000308	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.24e-05	0.000308	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CTNNB1—melanoma	2.23e-05	0.000307	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.23e-05	0.000307	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.23e-05	0.000306	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.22e-05	0.000306	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1B1—melanoma	2.2e-05	0.000303	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—melanoma	2.19e-05	0.000301	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NFKB1—melanoma	2.17e-05	0.000298	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	2.16e-05	0.000297	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PRKCA—melanoma	2.15e-05	0.000295	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGB1—melanoma	2.14e-05	0.000294	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ERCC2—melanoma	2.13e-05	0.000293	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACER3—melanoma	2.08e-05	0.000287	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP17A1—melanoma	2.06e-05	0.000283	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PHGDH—melanoma	2.04e-05	0.000281	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LUM—melanoma	2.04e-05	0.000281	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.03e-05	0.000279	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PHGDH—melanoma	2.03e-05	0.000279	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LUM—melanoma	2.03e-05	0.000279	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.01e-05	0.000276	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HPSE—melanoma	2e-05	0.000275	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HPSE—melanoma	1.99e-05	0.000274	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	1.98e-05	0.000272	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—melanoma	1.97e-05	0.00027	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CUBN—melanoma	1.96e-05	0.00027	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HGF—melanoma	1.95e-05	0.000269	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CUBN—melanoma	1.95e-05	0.000269	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—melanoma	1.95e-05	0.000268	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GNA11—melanoma	1.95e-05	0.000268	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.94e-05	0.000267	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—NRAS—melanoma	1.94e-05	0.000267	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CSF2—melanoma	1.93e-05	0.000266	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—melanoma	1.92e-05	0.000264	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	1.91e-05	0.000262	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UGT2B10—melanoma	1.91e-05	0.000262	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—FASN—melanoma	1.9e-05	0.000262	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SDHD—melanoma	1.9e-05	0.000261	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CSPG4—melanoma	1.9e-05	0.000261	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BSG—melanoma	1.9e-05	0.000261	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SDHD—melanoma	1.89e-05	0.000259	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CSPG4—melanoma	1.89e-05	0.000259	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BSG—melanoma	1.89e-05	0.000259	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SLC5A5—melanoma	1.87e-05	0.000258	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—melanoma	1.86e-05	0.000256	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PRKCA—melanoma	1.85e-05	0.000255	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGB3—melanoma	1.85e-05	0.000255	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPAM—melanoma	1.84e-05	0.000253	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPAM—melanoma	1.83e-05	0.000251	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CG—melanoma	1.82e-05	0.000251	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ABCB1—melanoma	1.81e-05	0.000249	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GNAQ—melanoma	1.81e-05	0.000249	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD44—melanoma	1.81e-05	0.000249	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HS3ST5—melanoma	1.77e-05	0.000244	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.77e-05	0.000244	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—melanoma	1.77e-05	0.000243	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—melanoma	1.77e-05	0.000243	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CG—melanoma	1.77e-05	0.000243	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—melanoma	1.76e-05	0.000242	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.75e-05	0.000241	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	1.74e-05	0.00024	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1B1—melanoma	1.73e-05	0.000238	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH1—melanoma	1.72e-05	0.000236	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAC1—melanoma	1.72e-05	0.000236	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—melanoma	1.71e-05	0.000235	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—melanoma	1.68e-05	0.000232	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	1.68e-05	0.000231	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—melanoma	1.67e-05	0.00023	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PRKCA—melanoma	1.67e-05	0.00023	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MMP1—melanoma	1.66e-05	0.000228	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ERCC2—melanoma	1.65e-05	0.000228	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CDK2—melanoma	1.63e-05	0.000224	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CD—melanoma	1.6e-05	0.000221	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	1.59e-05	0.000219	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—melanoma	1.58e-05	0.000218	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLA2G6—melanoma	1.56e-05	0.000215	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CD—melanoma	1.55e-05	0.000214	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLA2G6—melanoma	1.55e-05	0.000214	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—melanoma	1.53e-05	0.000211	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.53e-05	0.00021	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—FN1—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.51e-05	0.000208	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—melanoma	1.5e-05	0.000206	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CG—melanoma	1.45e-05	0.000199	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EGF—melanoma	1.43e-05	0.000197	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—melanoma	1.43e-05	0.000196	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—melanoma	1.42e-05	0.000195	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—VCAN—melanoma	1.4e-05	0.000193	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CB—melanoma	1.4e-05	0.000192	CbGpPWpGaD
Repaglinide—ALB—Metabolism—VCAN—melanoma	1.39e-05	0.000192	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—melanoma	1.38e-05	0.00019	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.37e-05	0.000189	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—melanoma	1.36e-05	0.000187	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CB—melanoma	1.36e-05	0.000186	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLCB4—melanoma	1.34e-05	0.000185	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—melanoma	1.34e-05	0.000185	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.33e-05	0.000183	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF1—melanoma	1.33e-05	0.000183	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.32e-05	0.000182	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.31e-05	0.000181	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PRKCA—melanoma	1.31e-05	0.000181	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CG—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ERCC2—melanoma	1.3e-05	0.000179	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.28e-05	0.000176	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CD—melanoma	1.28e-05	0.000175	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.27e-05	0.000175	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC6A11—melanoma	1.26e-05	0.000174	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.26e-05	0.000174	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—melanoma	1.25e-05	0.000172	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTAP—melanoma	1.23e-05	0.000169	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—melanoma	1.21e-05	0.000166	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP17A1—melanoma	1.18e-05	0.000163	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP17A1—melanoma	1.18e-05	0.000162	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—melanoma	1.17e-05	0.000161	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.17e-05	0.000161	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.16e-05	0.00016	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.15e-05	0.000159	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CD—melanoma	1.15e-05	0.000158	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—melanoma	1.13e-05	0.000156	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNA11—melanoma	1.12e-05	0.000154	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNA11—melanoma	1.11e-05	0.000153	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CB—melanoma	1.11e-05	0.000153	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LUM—melanoma	1.1e-05	0.000151	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PHGDH—melanoma	1.1e-05	0.000151	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FASN—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FASN—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.08e-05	0.000148	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC5A5—melanoma	1.08e-05	0.000148	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HPSE—melanoma	1.07e-05	0.000148	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.07e-05	0.000148	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC5A5—melanoma	1.07e-05	0.000147	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CUBN—melanoma	1.05e-05	0.000145	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNAQ—melanoma	1.04e-05	0.000143	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD44—melanoma	1.04e-05	0.000143	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNAQ—melanoma	1.03e-05	0.000142	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD44—melanoma	1.03e-05	0.000142	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—melanoma	1.03e-05	0.000142	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDHD—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BSG—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CSPG4—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.02e-05	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.01e-05	0.000139	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.01e-05	0.000139	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1e-05	0.000138	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CB—melanoma	1e-05	0.000138	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1B1—melanoma	9.96e-06	0.000137	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—melanoma	9.93e-06	0.000137	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—melanoma	9.92e-06	0.000136	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1B1—melanoma	9.91e-06	0.000136	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPAM—melanoma	9.86e-06	0.000136	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—melanoma	9.51e-06	0.000131	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—melanoma	9.25e-06	0.000127	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CD—melanoma	9.05e-06	0.000124	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—melanoma	8.93e-06	0.000123	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.79e-06	0.000121	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.74e-06	0.00012	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—melanoma	8.67e-06	0.000119	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—melanoma	8.65e-06	0.000119	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—melanoma	8.57e-06	0.000118	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—melanoma	8.52e-06	0.000117	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G6—melanoma	8.38e-06	0.000115	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—melanoma	8.26e-06	0.000114	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—melanoma	8.21e-06	0.000113	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—melanoma	8.2e-06	0.000113	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—melanoma	8.16e-06	0.000112	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CB—melanoma	7.89e-06	0.000108	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—melanoma	7.81e-06	0.000107	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—melanoma	7.81e-06	0.000107	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PRKCA—melanoma	7.55e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—VCAN—melanoma	7.53e-06	0.000104	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PRKCA—melanoma	7.51e-06	0.000103	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ERCC2—melanoma	7.49e-06	0.000103	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ERCC2—melanoma	7.45e-06	0.000102	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—melanoma	7.37e-06	0.000101	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—melanoma	6.96e-06	9.57e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—melanoma	6.81e-06	9.37e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—melanoma	6.77e-06	9.32e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—melanoma	6.75e-06	9.28e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—melanoma	6.55e-06	9.01e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—melanoma	6.41e-06	8.82e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP17A1—melanoma	6.35e-06	8.74e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—melanoma	6.27e-06	8.62e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.2e-06	8.53e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.17e-06	8.48e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—melanoma	6.11e-06	8.4e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNA11—melanoma	6e-06	8.25e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—melanoma	5.91e-06	8.13e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—melanoma	5.88e-06	8.09e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FASN—melanoma	5.87e-06	8.08e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC5A5—melanoma	5.78e-06	7.94e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—melanoma	5.71e-06	7.85e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—melanoma	5.68e-06	7.81e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD44—melanoma	5.58e-06	7.67e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNAQ—melanoma	5.58e-06	7.67e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—melanoma	5.53e-06	7.61e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1B1—melanoma	5.35e-06	7.36e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CD—melanoma	5.2e-06	7.15e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CD—melanoma	5.17e-06	7.11e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—melanoma	5.13e-06	7.06e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—melanoma	4.99e-06	6.86e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—melanoma	4.81e-06	6.61e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CB—melanoma	4.53e-06	6.23e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CB—melanoma	4.51e-06	6.2e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—melanoma	4.49e-06	6.18e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—melanoma	4.46e-06	6.14e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—melanoma	4.4e-06	6.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PRKCA—melanoma	4.05e-06	5.57e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ERCC2—melanoma	4.02e-06	5.53e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—melanoma	3.93e-06	5.4e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—melanoma	3.92e-06	5.39e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—melanoma	3.89e-06	5.36e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—melanoma	3.17e-06	4.37e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—melanoma	3.06e-06	4.21e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CD—melanoma	2.79e-06	3.84e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—melanoma	2.76e-06	3.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—melanoma	2.75e-06	3.79e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—melanoma	2.75e-06	3.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CB—melanoma	2.43e-06	3.35e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—melanoma	2.41e-06	3.32e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—melanoma	2.26e-06	3.1e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—melanoma	2.24e-06	3.09e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—melanoma	2.1e-06	2.89e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—melanoma	1.48e-06	2.04e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—melanoma	1.21e-06	1.67e-05	CbGpPWpGaD
